Why is damage limited to the mucosa in ulcerative colitis but transmural in Crohn's disease?
- PMID: 23946890
- PMCID: PMC3740262
- DOI: 10.4291/wjgp.v4.i3.63
Why is damage limited to the mucosa in ulcerative colitis but transmural in Crohn's disease?
Abstract
It has been a big puzzle as why the inflammation of ulcerative colitis (UC) is limited to the mucosa, while in Crohn's disease (CD) the inflammation is transmural and can be seen in all layers of the gut. Here, I give a tentative explanation extended from the unified hypothesis I proposed on the etiology of inflammatory bowel disease. This hypothesis suggested that both UC and CD are caused by weakening of the gut barrier due to damage of the protective mucus layer and the underlying tissue by the poorly inactivated digestive proteases resulting from a reduction of gut bacteria by dietary chemicals like saccharin and sucralose. However, the large amounts of bacteria in the colon make the recruitment of neutrophils and formation of crypt abscess the main manifestation of UC, while the infiltration of antigens and dietary particles in the small and large intestine mainly cause the recruitment of macrophages and formation of granulomas as the main manifestations in CD. The fast reacting and short life span of neutrophils make the fight and damage limited to the surface of the mucosa. In contrast, the long life span and constant movement of macrophages may bring the harmful agents deep into the tissue. Therefore, the pathogenesis of UC may be more like bacterial pneumonia, while CD may be more like pneumoconiosis or tuberculosis of the lung.
Keywords: Crohn’s disease; Inflammatory bowel disease; Macrophages; Neutrophils; Pathogenesis; Ulcerative colitis.
Similar articles
-
Etiology of inflammatory bowel disease: a unified hypothesis.World J Gastroenterol. 2012 Apr 21;18(15):1708-22. doi: 10.3748/wjg.v18.i15.1708. World J Gastroenterol. 2012. PMID: 22553395 Free PMC article. Review.
-
Specific Norovirus Interaction with Lewis x and Lewis a on Human Intestinal Inflammatory Mucosa during Refractory Inflammatory Bowel Disease.mSphere. 2021 Jan 13;6(1):e01185-20. doi: 10.1128/mSphere.01185-20. mSphere. 2021. PMID: 33441404 Free PMC article.
-
Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).Hepatogastroenterology. 1998 May-Jun;45(21):691-9. Hepatogastroenterology. 1998. PMID: 9684118
-
Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy.Dig Dis. 2014;32(4):475-83. doi: 10.1159/000358156. Epub 2014 Jun 23. Dig Dis. 2014. PMID: 24969297 Review.
-
Granulomatous ulcerative colitis: a re-appraisal of the mucosal granuloma in the distinction of Crohn's disease from ulcerative colitis.Histopathology. 2002 Jul;41(1):50-5. doi: 10.1046/j.1365-2559.2002.01416.x. Histopathology. 2002. PMID: 12121237
Cited by
-
Anti-Inflammatory Potential of Brassicaceae-Derived Phytochemicals: In Vitro and In Vivo Evidence for a Putative Role in the Prevention and Treatment of IBD.Nutrients. 2022 Dec 21;15(1):31. doi: 10.3390/nu15010031. Nutrients. 2022. PMID: 36615689 Free PMC article. Review.
-
A Noninvasive Method to Assess Mucosal Healing in Patients* With Crohn's Disease.Gastroenterol Hepatol (N Y). 2018 May;14(5 Suppl 2):1-12. Gastroenterol Hepatol (N Y). 2018. PMID: 29991933 Free PMC article.
-
Interplay of broccoli/broccoli sprout bioactives with gut microbiota in reducing inflammation in inflammatory bowel diseases.J Nutr Biochem. 2023 Mar;113:109238. doi: 10.1016/j.jnutbio.2022.109238. Epub 2022 Nov 26. J Nutr Biochem. 2023. PMID: 36442719 Free PMC article. Review.
-
Management of pembrolizumab-induced steroid refractory mucositis with infliximab: A case report.World J Clin Cases. 2020 Sep 26;8(18):4100-4108. doi: 10.12998/wjcc.v8.i18.4100. World J Clin Cases. 2020. PMID: 33024767 Free PMC article.
-
Location-based prediction model for Crohn's disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodies.World J Gastroenterol. 2023 Nov 14;29(42):5728-5750. doi: 10.3748/wjg.v29.i42.5728. World J Gastroenterol. 2023. PMID: 38075846 Free PMC article.
References
-
- Colombel JF, Watson AJ, Neurath MF. The 10 remaining mysteries of inflammatory bowel disease. Gut. 2008;57:429–433. - PubMed
-
- Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427–434. - PubMed
-
- Turk JL, Narayanan RB. The monocyte-macrophage system in granulomatous inflammation. Haematol Blood Transfus. 1981;27:101–107. - PubMed
-
- Epstein WL, Fukuyama K. Mechanisms of granulomatous inflammation. Immunol Ser. 1989;46:687–721. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources